title: Defining the extent of cables loss in endometrial cancer subtypes and its effectiveness as an inhibitor of cell proliferation in malignant endometrial cells in vitro and in vivo.
abstract: Loss of Cables expression is associated with a high incidence of endometrial hyperplasia and endometrial adenocarcinoma in humans. The Cables mutant mouse develops endometrial hyperplasia and following exposure to chronic estrogen develops early endometrial adenocarcinoma. The objectives of the current study were to determine if: (1) loss of Cables expression occurred in high grade endometrioid adenocarcinoma, uterine serous and clear cell carcinoma as observed in endometrial hyperplasia and low grade endometrial adenocarcinoma; (2) overexpression of Cables inhibited cell proliferation in endometrial cancer (EC) cells in vitro and in vivo; and (3) progesterone could regulate the expression of Cables mRNA. Hyperplastic endometrium and low and high grade endometrioid adenocarcinoma showed loss of Cables expression when compared to benign control secretory endometrium. Loss of Cables expression in serous and clear cell tumors was similar to that observed in endometrioid adenocarcinomas with greater than 80% showing loss of protein expression. Treatment of EC lines with progesterone increased cables expression in low-grade EC whereas it had no effect on cables expression in cells derived from high-grade EC. The progesterone-induced increase in cables was abrogated in the presence of a progesterone receptor (PR) antagonist, suggesting the PR mediates the increase. Cables overexpression inhibited cell proliferation of well differentiated EC cells and had no effect on the poorly differentiated EC cells. The capacity to form tumors was dramatically reduced in the Cables overexpressing cell lines compared to those cells containing the control vector. Collectively these results suggest that Cables is an important regulator of cell proliferation and loss of Cables expression contributes to the development of all types of EC.
authors.affiliation: Vincent Center for Reproductive Biology, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
authors.forename: Robert L
authors.initials: RL
authors.lastname: DeBernardo
authors.forename: Ramey D
authors.initials: RD
authors.lastname: Littell
authors.forename: Hongwei
authors.initials: H
authors.lastname: Luo
authors.forename: Linda R
authors.initials: LR
authors.lastname: Duska
authors.forename: Esther
authors.initials: E
authors.lastname: Oliva
authors.forename: Sandra D
authors.initials: SD
authors.lastname: Kirley
authors.forename: Maureen P
authors.initials: MP
authors.lastname: Lynch
authors.forename: Lawrence R
authors.initials: LR
authors.lastname: Zukerberg
authors.forename: Bo R
authors.initials: BR
authors.lastname: Rueda
mesh_terms: D000230:Adenocarcinoma / Q000235:genetics* / Q000473:pathology*; D018262:Adenocarcinoma, Clear Cell / Q000235:genetics* / Q000473:pathology*; D000818:Animals; D002352:Carrier Proteins; D049109:Cell Proliferation; D016213:Cyclins; D016889:Endometrial Neoplasms / Q000235:genetics* / Q000473:pathology*; D005260:Female; D020869:Gene Expression Profiling; D006801:Humans; D051379:Mice; D010750:Phosphoproteins; D011980:Receptors, Progesterone / Q000502:physiology; D014407:Tumor Cells, Cultured
chemical_list: C486568:CABLES1 protein, human; D002352:Carrier Proteins; D016213:Cyclins; D010750:Phosphoproteins; D011980:Receptors, Progesterone